HomeFile

File

View Category
Chronic Ischemic cardiopathy

Additional Benefit from Radial Artery Graft in Myocardial Revascularization Surgery

Used to different extents according to institution, surgeon, and historical time, the radial artery graft is yet...
solaci -
Learn More
Most Read Scientific Articles

CLOSE Trial: Patients with PFO with high flow or associated with interatrial septal aneurysm receiving closure device experience lower rates of recurrent stroke

Several cases have shown an association between patent foramen ovale and cryptogenic shock, particularly in patients under...
solaci -
Learn More
Peripheral vascular disease

The need for dialysis after TAVR increases mortality

Courtesy of Dr. Carlos Fava. Stage III or higher renal impairment is frequent before TAVR, and the need for...
solaci -
Learn More
Most Read Scientific Articles

REDUCE Trial: Patients with PFO and cryptogenic stroke at lower risk of recurrent stoke when treated with APT and closure device

Courtesy of Dr. José Álvarez. This is a multicenter randomized study on patients with patent foramen ovale (PFO)...
solaci -
Learn More
Most Read Scientific Articles

Long-term results of the RESPECT study favor closure with the Amplatzer device

Courtesy of Dr. José Álvarez. The RESPECT trial is a multicenter randomized trial with blinded adjudication of end-point...
solaci -
Learn More
Chronic Ischemic cardiopathy

Is Same-Day Discharge After Angioplasty Safe?

Overnight observation after coronary angioplasty has been the standard of care in the United States. The foundations for...
solaci -
Learn More
Chronic Ischemic cardiopathy

SYNTAX II: Better Stents, IVUS, FFR, or a Combination of All of Them to Catch Up with Surgery

In patients with 3-vessel disease, surgery obtained better outcomes than angioplasty, according to results from the SYNTAX...
solaci -
Learn More
HIGHLIGHTS

FOURIER: Efficacy of Evolocumab for Ultra-Low LDL Levels

It seems that a LDL level of 70 mg/dL is no longer low enough for high-risk secondary patients;...
solaci -
Learn More